Novavax to Report First Quarter 2026 Financial Results on May 6, 2026
Novavax (Nasdaq: NVAX) will report first quarter 2026 financial results and operational highlights on May 6, 2026 at 8:30 a.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Novavax (Nasdaq: NVAX) will report first quarter 2026 financial results and operational highlights on May 6, 2026 at 8:30 a.m. ET. A live webcast and conference call will be available, with replay access from 11:30 a.m. ET May 6 through 11:59 p.m. ET May 13, 2026.
Participants may register for automated call-back or dial in directly; the webcast will remain on the investor site through June 6, 2026.
Details
News Market Reaction – NVAX
On Apr 30, the first trading day after this news, NVAX closed 0.56% below the previous close.
Data tracked by StockTitan Argus for the Apr 30 session.
Key Figures
- Earnings call date
- May 6, 2026
- Scheduled Q1 2026 results conference call
- Earnings call time
- 8:30 a.m. ET
- Start time for Q1 2026 call
- US dial-in
- (888) 880-3330
- Domestic conference call number
- International dial-in
- (+1) (646) 357-8766
- International conference call number
- Replay window (phone)
- May 6–13, 2026
- Replay available from 11:30 a.m. ET May 6 to 11:59 p.m. ET May 13
- Replay US dial-in
- (800) 770-2030
- Domestic replay number
- Replay passcode
- 1309751#
- Passcode to access phone replay
- Webcast availability
- Until June 6, 2026
- Archived webcast on ir.novavax.com/events
Previous Earnings date Reports
-
Scheduled Q4 and full-year 2025 earnings call with access details for investors.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Conference call details: | |
Date: | May 6, 2026 |
Time: | 8:30 a.m. ET |
URL to register phone: | |
Dial-in number: | (888) 880-3330 ( |
(+1) (646) 357-8766 (International) | |
Webcast: |
- Participants can join the conference call without operator assistance by registering and entering their phone number with the above URL to receive an instant automated call back.
- Participants can also dial direct to be entered into the call by an operator and will be prompted to request to join the Novavax, Inc. call.
- To ensure a timely connection, it is recommended that participants join at least 10 minutes prior to the scheduled start time.
Replay details: | |
Date: | Available starting at 11:30 a.m. ET, May 6, 2026, until 11:59 p.m. ET, May 13, 2026 |
Dial-in number: | (800) 770-2030 ( |
(+1) (609) 800-9909 (International) | |
Passcode: | 1309751# |
Webcast: | ir.novavax.com/events, until June 6, 2026 |
About Novavax
Novavax, Inc. (Nasdaq: NVAX) tackles some of the world's most pressing health challenges with its scientific expertise in vaccines and its proven technology platform, including its Matrix-M® adjuvant and protein-based nanoparticles. The Company's growth strategy focuses on maximizing the impact of its cutting-edge technology by forging strategic partnerships for its Matrix-M adjuvant and R&D assets. Please visit novavax.com and LinkedIn for more information.
Contacts:
Investors
Jim Kelly
844-668-2829
ir@novavax.com
Media
Yvonne Sprow
844-264-8571
media@novavax.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-report-first-quarter-2026-financial-results-on-may-6-2026-302757475.html
SOURCE Novavax, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.